CD4 cell count before chronic hepatitis C (HCV) treatment with direct-acting antivirals (DAAs) and at the end of follow-up in HCV/HIV co-infected patients

被引：0
|
作者：
Mendez, Josefina [1 ]
Soeiro, Cristina [1 ]
Marques, Marta [1 ]
Goncalves, Celina [1 ]
Tavares, Ana Paula [1 ]
Horta, Ana [1 ]
Vasconcelos, Olga [1 ]
Seabra, Joao [1 ]
Abreu, Miguel [1 ]
Sarmento e Castro, Rui [1 ]
机构：
[1] Ctr Hosp Porto, Infect Dis, Oporto, Portugal
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2016年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P299
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Response to direct-acting antivirals for hepatitis C treatment in vertically HIV/HCV co-infected patients
    Carrasco, Itziar
    Sainz, Talia
    Antoinette Frick, Marie
    Jimenez de Ory, Santiago
    Fortuny, Claudia
    Burgos, Joaquin
    Montero, Marta
    Gavilan, Cesar
    Dolores Falcon, Maria
    Antonio Couceiro, Jose
    Ignacio Bernardino, Jose
    Bisbal, Otilia
    Guerrero, Carmelo
    Teresa Aldamiz-Echevarria, Maria
    Berenguer, Juan
    Luisa Navarro, Maria
    [J]. JOURNAL OF VIRAL HEPATITIS, 2020, 27 (09) : 955 - 958
  • [2] Hepatitis C Direct-Acting Antiviral Agents in HIV/HCV Co-infected Patients
    Valérie Martel-Laferrière
    Douglas T. Dieterich
    [J]. Current Treatment Options in Infectious Diseases, 2014, 6 (2) : 132 - 143
  • [3] Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA)
    L. Dold
    C. Schwarze-Zander
    C. Boesecke
    R. Mohr
    B. Langhans
    J.-C. Wasmuth
    C. P. Strassburg
    J. K. Rockstroh
    U. Spengler
    [J]. Scientific Reports, 9
  • [4] Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA)
    Dold, L.
    Schwarze-Zander, C.
    Boesecke, C.
    Mohr, R.
    Langhans, B.
    Wasmuth, J-C
    Strassburg, C. P.
    Rockstroh, J. K.
    Spengler, U.
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [5] Direct-acting Antivirals for HIV/HCV Co-infected Individuals: As Good as it Gets?
    Bruno, Giuseppe
    Saracino, Annalisa
    [J]. CURRENT HIV RESEARCH, 2017, 15 (06) : 422 - 433
  • [6] Occurrence of hepatocellular carcinoma in HIV/HCV co-infected patients treated with direct-acting antivirals
    Hasson, Hamid
    Merli, Marco
    Messina, Emanuela
    Bhoori, Sherrie
    Salpietro, Stefania
    Morsica, Giulia
    Regalia, Enrico
    Bagaglio, Sabrina
    Lazzarin, Adriano
    Uberti-Foppa, Caterina
    Mazzaferro, Vincenzo
    [J]. JOURNAL OF HEPATOLOGY, 2017, 67 (02) : 415 - 417
  • [7] Lipid Profiles After Therapy with Direct-Acting Antivirals in HCV Mono-infected and HCV/HIV Co-infected Patients
    Simmons, Okeefe L.
    Drechsler, Henning
    Kouma, Marcus
    Brown, Geri
    Bedimo, Roger
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S343 - S343
  • [8] Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals
    Rockstroh, Juergen K.
    [J]. LIVER INTERNATIONAL, 2015, 35 : 51 - 55
  • [9] Impact of Directly Acting Antivirals (DAAs) Treatment on Rates of Hepatocellular Carcinoma (HCC) in Hepatitis C Virus (HCV) and HIV Co-infected Patients
    Bari, Shahla
    Chan, Austin
    Olanipekun, Titilope
    Chawla, Saurabh
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S493 - S494
  • [10] Impact of treatment with direct-acting antivirals on inflammatory markers and autoantibodies in HIV/HCV co-infected individuals
    Rossotti, Roberto
    Merli, Marco
    Baiguera, Chiara
    Bana, Nicholas Brian
    Rezzonico, Leonardo Francesco
    D'Amico, Federico
    Raimondi, Alessandro
    Moioli, Maria Cristina
    Chianura, Leonardo Gerolamo
    Puoti, Massimo
    [J]. JOURNAL OF VIRAL HEPATITIS, 2023, 30 (06) : 530 - 539
12345